TABLE 2

Response to bronchial thermoplasty at 12 months post procedure

Baseline12 months post bronchial thermoplastyp-value
Symptom score (ACQ)3.3±1.02.0±1.30.001
SABA (puffs·day−1)10 (14)2 (6)0.001
Prednisolone dose (mg·day−1)7 (15)0 (10)0.001
Exacerbations (per annum)4 (8)1 (3)0.001
FEV1 (L)1.43±0.631.51±0.700.140
FEV1 (% pred)49.1±15.852.7±18.10.035
Vital capacity (L)2.91±0.943.01±1.000.078
TLC (L)6.01±1.435.95±1.420.338
TLC (% pred)104.7±17.4103.9±20.60.567
RV (L)3.09±0.952.93±0.940.026
RV (% pred)150.3±40.8141.8±46.00.023
RV/TLC (%)51.3±10.549.3±10.80.009

Data are presented as mean±sd or median (interquartile range), unless otherwise stated. Bold type represents statistical significance. n=43. ACQ: Asthma Control Questionnaire; SABA: short-acting β-agonist; FEV1: forced expiratory volume in 1 s; TLC: total lung capacity; RV: residual volume.